Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0% · short 10.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for BG Medicine, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as heart attack and stroke. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was incorporated in 2000 and is headquartered in Waltham, Massachusetts.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
30 buys63 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Adourian Aram S. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Adourian Aram S. | Exercise | $10.8K | SEC |
| Adourian Aram S. | Other | $5.2K | SEC |
| Adourian Aram S. | Other | $2.7K | SEC |
| HALL STEPHEN P | Other | $3.2K | SEC |
| SOHMER PAUL R | Other | $5.6K | Unusual size | SEC |
| HALL STEPHEN P | Other | $6.2K | SEC |
| LUBER JEFFREY R | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| AFEYAN NOUBARtrack record | Sell | $1.4K | SEC |
| AFEYAN NOUBARtrack record | Sell | $24.6K | Unusual size | SEC |
| OCONNOR JAMES F O | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILCOX HARRY W | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| AFEYAN NOUBARtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PAPADOPOULOS STELIOStrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Adourian Aram S. | Other | $5.2K | SEC |
| SOHMER PAUL R | Other | $11.1K | SEC |
| Flagship Ventures Management, Inc. | Other | $35.6 | SEC |
| Flagship Ventures Management, Inc. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Applied Genomic Technology Capital Fund LPtrack record | Sell | $601.6 | SEC |
| Applied Genomic Technology Capital Fund LPtrack record | Other | $588.7 | SEC |
| Flagship Ventures Management, Inc. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Flagship Ventures Management, Inc. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Flagship Ventures Management, Inc. | Sell | $36.3 | SEC |
| Flagship Ventures Management, Inc. | Sell | $467.6 | Unusual size | SEC |
| Flagship Ventures Management, Inc. | Other | $71.1 | SEC |